Can Fite Biopharma Ltd
F:CF5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Can Fite Biopharma Ltd
F:CF5
|
IL |
|
D
|
DGO Gold Ltd
F:48D
|
AU |
|
Cardiff Lexington Corp
OTC:CDIX
|
US |
|
W
|
Wavestone SA
SWB:2WSA
|
FR |
|
E
|
ES Group (Holdings) Ltd
SGX:ESG
|
SG |
|
C
|
Cytokinetics Inc
XMUN:KK3A
|
US |
|
D
|
Daesang Holdings Co Ltd
KRX:084695
|
KR |
|
O
|
Opdenergy Holding SA
F:69J
|
ES |
|
A
|
Australian Agricultural Company Ltd
XMUN:AY5
|
AU |
|
Bolt Biotherapeutics Inc
F:6LP
|
US |
|
Newcore Gold Ltd
F:PI8
|
CA |
|
R
|
Rua Life Sciences PLC
F:AOHA
|
UK |
|
B
|
BonTerra Resources Inc
F:9BR2
|
CA |
|
U
|
Uniti Group Inc
F:8XC
|
US |
|
Tarena International Inc
F:0T8B
|
CN |
|
Elementos Ltd
F:9EM
|
AU |
|
Lovable Lingerie Ltd
BSE:533343
|
IN |
|
U
|
Ultra Clean Holdings Inc
F:UCE
|
US |
|
Tevogen Bio Holdings Inc
F:G28
|
US |
Bankruptcy Probability
Can Fite Biopharma Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Can Fite Biopharma Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IL |
C
|
Can Fite Biopharma Ltd
TASE:CANF
|
22.9m ILS |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
470B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
239.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
139.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
86.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Can Fite Biopharma Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Can Fite Biopharma Ltd has no debt.
You can find a full breakdown on its Balance Sheet.
